Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia. [electronic resource]
Producer: 20150102Description: 2011-8 p. digitalISSN:- 1432-0584
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Blood Component Transfusion
- Combined Modality Therapy
- Consolidation Chemotherapy
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Diarrhea -- chemically induced
- Drug Administration Schedule
- Drug Evaluation
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematopoietic Stem Cell Transplantation
- Humans
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- drug therapy
- Liposomes
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Proportional Hazards Models
- Remission Induction
- Retrospective Studies
- Salvage Therapy
- Vidarabine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.